NCT07646535 clinical trial report covering SAL-0140, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07646080 clinical trial report covering Anlotinib Dihydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07645287 clinical trial report covering GS-3242, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07644559 clinical trial report covering Cetuximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07643766 clinical trial report covering ENV-294, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07645326 clinical trial report covering Docetaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07645118 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07646301 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07645157 clinical trial report covering Sertraline Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07645300 clinical trial report covering Spironolactone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07644312 clinical trial report covering Nivolumab/Relatlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07648745 clinical trial report covering Cediranib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.